Implants News and Research RSS Feed - Implants News and Research

Sugar-based molecular microcapsule eliminates toxicity of anticancer agent

Sugar-based molecular microcapsule eliminates toxicity of anticancer agent

Johns Hopkins researchers have developed a sugar-based molecular microcapsule that eliminates the toxicity of an anticancer agent developed a decade ago at Johns Hopkins, called 3-bromopyruvate, or 3BrPA, in studies of mice with implants of human pancreatic cancer tissue. The encapsulated drug packed a potent anticancer punch, stopping the progression of tumors in the mice, but without the usual toxic effects. [More]
Champions reports decrease in revenue for second quarter of 2015

Champions reports decrease in revenue for second quarter of 2015

Champions Oncology, Inc., engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced its financial results for the second quarter ended October 31, 2014. [More]
WSU researchers working on better bone-like materials used in hip and knee replacements

WSU researchers working on better bone-like materials used in hip and knee replacements

Washington State University researchers are working to improve materials used in hip and knee replacements so that they last longer and allow patients to quickly get back on their feet after surgery. [More]
SI-BONE wins Gold 2014 International MarCom Award for SI Joint Patient Community website

SI-BONE wins Gold 2014 International MarCom Award for SI Joint Patient Community website

SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant System, a minimally invasive surgical (MIS) device indicated for fusion for certain disorders of the sacroiliac (SI) joint, won the Gold 2014 International MarCom Award for its SI Joint Patient Community website and an Honorable Mention for the SI Buddy Patient Networking Program. [More]
Tecomet completes acquisition of Symmetry Medical's OEM Solutions business

Tecomet completes acquisition of Symmetry Medical's OEM Solutions business

Tecomet Inc., a Genstar Capital portfolio company and precision contract manufacturer supporting the medical device and aerospace industries, announced today that it has completed the previously announced acquisition of Symmetry Medical's OEM Solutions business. This acquisition creates the largest orthopedic contract manufacturer in the world with 18 facilities located in five countries on three continents. [More]
Researchers figure out how to reverse characteristics of polyurea materials

Researchers figure out how to reverse characteristics of polyurea materials

Researchers at the University of Illinois at Urbana-Champaign have figured out how to reverse the characteristics of a key bonding material--polyurea--providing an inexpensive alternative for a broad number of applications, such as drug delivery, tissue engineering, and packaging. [More]
Breakthrough research could lead to prosthetic retinas for people suffering from retinal damage

Breakthrough research could lead to prosthetic retinas for people suffering from retinal damage

Scientists have developed a new light-sensitive film that could one day form the basis of a prosthetic retina to help people suffering from retinal damage or degeneration. Hebrew University of Jerusalem researchers collaborated with colleagues from Tel Aviv University and Newcastle University in the research, which was published in the journal Nano Letters. [More]

BME announces launch of Speed Arc Nitinol Fixation System

BioMedical Enterprises announced the launch of the Speed Arc Nitinol Fixation System, the world's first superelastic shape memory fixation device that conforms to the sloping surface of the metaphyseal anatomy. This addition to the current patented BME Speed Fixation System is available in three different sizes to ensure a proper fit in varying patient anatomies. [More]
BTG agrees to acquire PneumRx for $475 million

BTG agrees to acquire PneumRx for $475 million

PneumRx, Inc., a leader in the field of interventional pulmonology, today announced that it has signed an agreement to be acquired by BTG Plc in a deal worth up to $475 million, based on an initial consideration of $230 million and up to $245 million in performance-related milestone payments. [More]
Interventional radiology procedure can preserve fertility, save lives of women with placenta accreta

Interventional radiology procedure can preserve fertility, save lives of women with placenta accreta

Researchers reported today on a procedure that can preserve fertility and potentially save the lives of women with a serious pregnancy complication called placenta accreta. Results of the new study presented at the annual meeting of the Radiological Society of North America showed that placement of balloons in the main artery of the mother's pelvis prior to a Caesarean section protects against hemorrhage and is safe for both mother and baby. [More]
St. Mary's Medical Center adds Mazor Renaissance robot-assisted system to Spine Center

St. Mary's Medical Center adds Mazor Renaissance robot-assisted system to Spine Center

Dignity Health St. Mary's Medical Center has added the Mazor Robotics Renaissance computer-generated guidance system to its multidisciplinary Spine Center. St. Mary's is the only hospital in the Bay Area to exclusively offer this state-of-the-art technology for spine surgery. [More]
Benvenue Medical's Luna 360 System receives FDA clearance for spinal fusion treatment of DDD

Benvenue Medical's Luna 360 System receives FDA clearance for spinal fusion treatment of DDD

Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, today announced that the company's Luna 360 Interbody Fusion System has received 510(k) clearance from the U.S. Food and Drug Administration for spinal fusion treatment of symptomatic degenerative disc disease (DDD). [More]
Research findings have major implications for public dental health resources, costs for patients

Research findings have major implications for public dental health resources, costs for patients

The latest research from the University of Adelaide challenges current thinking on whether many people with tooth loss really need dentures. [More]
Prostate cancer patients with life expectancies of less than 10 years receive aggressive treatment

Prostate cancer patients with life expectancies of less than 10 years receive aggressive treatment

National guidelines recommend that men with low- and intermediate -risk prostate cancer and life expectancies of less than 10 years should not be treated with radiation or surgery, since they are unlikely to live long enough to benefit from treatment. Yet it is unknown whether such men are unnecessarily receiving these aggressive local treatments, putting them at risk for potentially debilitating side effects. [More]
DEX implant improves visual acuity in patients with diabetic macular oedema

DEX implant improves visual acuity in patients with diabetic macular oedema

Patients with diabetic macular oedema benefit from intravitreal dexamethasone implants, a study shows, with the treatment improving best-corrected visual acuity with an acceptable safety profile. [More]
Occlutech's PFO and ASD occluders to be launched in South Korea

Occlutech's PFO and ASD occluders to be launched in South Korea

Occlutech, a leading European innovator of products to treat structural heart disease today announced that it is making its range of PFO and ASD occluders available on the South Korean market. [More]

Centinel Spine releases next generation Lumbar Integrated Interbody fusion device

Centinel Spine, Inc., the pioneer of Stand-Alone, No-Profile fusion devices, introduced MIDLINE II, its next generation STALIF Family Lumbar Integrated Interbody fusion device. [More]
Eastern Europe restructures growth strategies to focus on medical devices sector

Eastern Europe restructures growth strategies to focus on medical devices sector

Governments in Eastern Europe have been forced to restructure their growth strategies and focus on attracting investors outside of the European Union in response to the Eurozone crisis. [More]
Cyberonics' worldwide net sales increase 5% to $73.4M in Q2 of fiscal 2015

Cyberonics' worldwide net sales increase 5% to $73.4M in Q2 of fiscal 2015

Cyberonics, Inc. today announced results for the quarter ended October 24, 2014. [More]

Synovasure PJI Alpha Defensin Test now available for sale in Europe

Zimmer today announced Synovasure PJI Alpha Defensin Test for Periprosthetic Joint Infection, the first and only test specifically designed for the diagnosis of Periprosthetic Joint Infection (PJI), is now eligible for sale in several European countries after earning key overseas certification this month. [More]